Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigate the Impact of Increased IgE on Innate Anti-herpes Simplex Virus 1 Responses in the Eczema Herpeticum Patients

NCT04060550 is registered in ClinicalTrials.gov with National Jewish Health as lead sponsor.

NCT NCT04060550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04060550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigate the Impact of Increased IgE on Innate Anti-herpes Simplex Virus 1 Responses in the Eczema Herpeticum Patients
Lead sponsor
National Jewish Health
Phase
Observational
Overall status
Unknown status
Start date
January 9, 2020
Completion date
July 31, 2021
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis with a history of eczema herpeticum, atopic dermatitis without a history of eczema herpeticum, health controls without atopy